BCDAW insider filings
BioCardia, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-07-02. Screen BCDAW transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for BCDAW between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — BioCardia, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-07-02 | 4 | Altman Peter — President and CEO, Director | Purchase (P): 200 @ $2.99 · Purchase (P): 300 @ $3.05 | EDGAR |
| 2024-06-24 | 4 | Altman Peter — President and CEO, Director | Purchase (P): 500 @ $3.29 | EDGAR |
| 2024-06-17 | 4 | Altman Peter — President and CEO, Director | Purchase (P): 500 @ $3.52 | EDGAR |
| 2024-06-12 | 4 | Altman Peter — President and CEO, Director | Purchase (P): 1,000 @ $3.36 | EDGAR |
| 2024-04-19 | 4 | Altman Peter — President and CEO, Director | Purchase (P): 2,750 @ $0.37 | EDGAR |
| 2024-03-28 | 4 | Altman Peter — President and CEO, Director | Purchase (P): 500 @ $0.39 | EDGAR |
| 2024-02-15 | 4 | Altman Peter — President and CEO, Director | Purchase (P): 108,108 @ $0.46 · Purchase (P): 54,054 (derivative) | EDGAR |
| 2023-10-19 | 4 | Facteau Bill — Director | Grant/award (A): 31,085 (derivative) @ $0 · Grant/award (A): 12,434 (derivative) @ $0 | EDGAR |
| 2023-10-19 | 4 | Blank Andrew Scott — Director | Grant/award (A): 12,434 (derivative) @ $0 | EDGAR |
| 2023-10-19 | 4 | Allen Jim L. — Director | Grant/award (A): 12,434 (derivative) @ $0 | EDGAR |
| 2023-10-19 | 4 | KRASNO RICHARD M — Director | Grant/award (A): 12,434 (derivative) @ $0 | EDGAR |
| 2023-10-19 | 4 | MOYES JAY M — Director | Grant/award (A): 12,434 (derivative) @ $0 | EDGAR |
| 2023-10-19 | 4 | STERTZER SIMON H — Director | Grant/award (A): 12,434 (derivative) @ $0 | EDGAR |
| 2023-08-18 | 4/A | Altman Peter — President and CEO, Director | Purchase (P): 4,000 @ $0.87 | EDGAR |
| 2023-08-18 | 4/A | Altman Peter — President and CEO, Director | Purchase (P): 4,500 @ $0.88 | EDGAR |
| 2023-08-17 | 4 | Altman Peter — President and CEO, Director | Grant/award (A): 4,000 @ $0.87 | EDGAR |
| 2023-08-14 | 4 | Altman Peter — President and CEO, Director | Grant/award (A): 4,500 @ $0.88 | EDGAR |
| 2023-06-26 | 4 | Blank Andrew Scott — Director | Grant/award (A): 64,212 @ $2.34 | EDGAR |
| 2023-06-26 | 4 | Allen Jim L. — Director | Grant/award (A): 64,212 @ $2.34 | EDGAR |
| 2023-06-26 | 4 | McClung David — Chief Financial Officer | Grant/award (A): 4,280 @ $2.34 | EDGAR |
| 2023-06-26 | 4 | Altman Peter — President and CEO, Director | Grant/award (A): 6,421 @ $2.34 | EDGAR |
| 2023-06-26 | 4 | STERTZER SIMON H — Director | Grant/award (A): 64,212 @ $2.34 | EDGAR |
| 2023-06-02 | 4 | McClung David — Chief Financial Officer | Tax withholding (F): 20,676 @ $1.77 | EDGAR |
| 2023-06-02 | 4 | Altman Peter — President and CEO, Director | Tax withholding (F): 36,821 @ $1.77 | EDGAR |
| 2023-06-02 | 4 | GILLIS EDWARD M — Senior Vice President, Devices | Tax withholding (F): 15,512 @ $1.77 | EDGAR |
| 2023-05-30 | 4 | Altman Peter — President and CEO, Director | Purchase (P): 6,200 @ $1.60 | EDGAR |
| 2023-05-22 | 4 | McClung David — Chief Financial Officer | Grant/award (A): 61,389 @ $1.70 · Grant/award (A): 68,265 (derivative) @ $0 | EDGAR |
| 2023-05-22 | 4 | Altman Peter — President and CEO, Director | Grant/award (A): 109,324 @ $1.70 · Grant/award (A): 159,723 (derivative) @ $0 | EDGAR |
| 2023-05-22 | 4 | GILLIS EDWARD M — Senior Vice President, Devices | Grant/award (A): 40,490 @ $1.70 · Grant/award (A): 43,803 (derivative) @ $0 | EDGAR |
| 2023-05-12 | 4 | ZSEBO KRISZTINA M — Director | Grant/award (A): 31,085 (derivative) @ $0 | EDGAR |
| 2023-04-14 | 4 | Altman Peter — President and CEO, Director | Purchase (P): 100 @ $1.87 | EDGAR |
| 2023-04-14 | 4/A | Altman Peter — President and CEO, Director | Grant/award (A): 3,498 @ $1.37 | EDGAR |
| 2023-04-07 | 4/A | McClung David — Chief Financial Officer | Grant/award (A): 17,347 @ $1.32 | EDGAR |
| 2023-04-07 | 4/A | Altman Peter — President and CEO, Director | Tax withholding (F): 26,458 @ $1.32 | EDGAR |
| 2022-12-19 | 4 | Blank Andrew Scott — Director | Grant/award (A): 148,809 @ $1.68 | EDGAR |
| 2022-12-19 | 4 | Allen Jim L. — Director | Grant/award (A): 148,809 @ $1.68 | EDGAR |
| 2022-12-19 | 4 | McClung David — Chief Financial Officer | Grant/award (A): 8,928 @ $1.68 | EDGAR |
| 2022-12-19 | 4 | Altman Peter — President and CEO, Director | Grant/award (A): 14,880 @ $1.68 | EDGAR |
| 2022-12-19 | 4 | STERTZER SIMON H — Director | Grant/award (A): 178,571 @ $1.68 | EDGAR |
| 2022-11-14 | 4 | Altman Peter — President and CEO, Director | Purchase (P): 3,100 @ $1.87 · Purchase (P): 1,400 @ $1.86 | EDGAR |
| 2022-10-11 | 4 | McClung David — Chief Financial Officer | Purchase (P): 2,000 @ $2.07 | EDGAR |
| 2022-09-30 | 4 | Blank Andrew Scott — Director | Grant/award (A): 12,434 (derivative) @ $0 | EDGAR |
| 2022-09-30 | 4 | Allen Jim L. — Director | Grant/award (A): 12,434 (derivative) @ $0 | EDGAR |
| 2022-09-30 | 4 | ZSEBO KRISZTINA M — Director | Grant/award (A): 12,434 (derivative) @ $0 | EDGAR |
| 2022-09-30 | 4 | KRASNO RICHARD M — Director | Grant/award (A): 12,434 (derivative) @ $0 | EDGAR |
| 2022-09-30 | 4 | MOYES JAY M — Director | Grant/award (A): 12,434 (derivative) @ $0 | EDGAR |
| 2022-09-30 | 4 | STERTZER SIMON H — Director | Grant/award (A): 12,434 (derivative) @ $0 | EDGAR |
| 2022-09-26 | 4 | Altman Peter — President and CEO, Director | Purchase (P): 3,100 @ $1.81 · Purchase (P): 1,400 @ $1.87 | EDGAR |
| 2022-09-22 | 4 | Altman Peter — President and CEO, Director | Purchase (P): 2,750 @ $1.92 | EDGAR |
| 2022-06-13 | 4 | Altman Peter — President and CEO, Director | Purchase (P): 4,500 @ $1.46 | EDGAR |
Recent 8-K events — BioCardia, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-20 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2026-11-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-11-06 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-19 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-07 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-01 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-23 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-21 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-09-10 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-24 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=BCDAW returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs